Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report.
作者信息
İnci Meltem, Gündüz Tuncay, Kürtüncü Murat, Eraksoy Mefküre
机构信息
Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Çapa, Fatih, Istanbul, Turkey.
出版信息
Acta Neurol Belg. 2022 Oct;122(5):1389-1391. doi: 10.1007/s13760-022-01953-w. Epub 2022 Apr 26.
PMID:35471765
Abstract
摘要
相似文献
1
Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report.一名多发性硬化症患者因阿仑单抗治疗导致复发性脑出血：病例报告。
Acta Neurol Belg. 2022 Oct;122(5):1389-1391. doi: 10.1007/s13760-022-01953-w. Epub 2022 Apr 26.
2
Intracerebral haemorrhage during alemtuzumab administration.使用阿仑单抗期间发生的脑出血。
Lancet Neurol. 2019 Apr;18(4):329-331. doi: 10.1016/S1474-4422(19)30076-6. Epub 2019 Feb 15.
3
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.在多发性硬化症中与阿仑单抗治疗相关的致死性不良事件。
BMC Res Notes. 2019 Aug 12;12(1):497. doi: 10.1186/s13104-019-4507-6.
4
D-dimer elevation after first alemtuzumab administration in a multiple sclerosis patient: case report.一名多发性硬化症患者首次使用阿仑单抗后D-二聚体升高：病例报告
Acta Neurol Belg. 2023 Feb;123(1):275-277. doi: 10.1007/s13760-021-01822-y. Epub 2021 Oct 24.
5
Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis.阿仑单抗治疗多发性硬化症第一周期后出现水痘和无症状新型冠状病毒肺炎
Neurol Sci. 2021 Oct;42(10):4003-4005. doi: 10.1007/s10072-021-05495-6. Epub 2021 Jul 31.
6
Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis.在接受来那度胺治疗的复发性多发性硬化症患者中，第 3 个周期时发生肺栓塞。
Mult Scler Relat Disord. 2019 Oct;35:5-6. doi: 10.1016/j.msard.2019.06.032. Epub 2019 Jun 29.
7
Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis.与多发性硬化症用阿仑单抗输注相关的急性心脏毒性。
Mult Scler. 2020 May;26(6):735-737. doi: 10.1177/1352458519855725. Epub 2020 Apr 16.
8
Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab.在使用阿仑单抗治疗多发性硬化症后，发生危及生命的自身免疫性温性溶血性贫血。
Mult Scler. 2018 May;24(6):811-813. doi: 10.1177/1352458517729766. Epub 2018 Jan 23.
9
Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease.阿仑单抗治疗多发性硬化症后出现复发性和普遍性斑秃：一种继发性自身免疫性疾病。
Mult Scler Relat Disord. 2019 Jan;27:406-408. doi: 10.1016/j.msard.2018.12.005. Epub 2018 Dec 3.
10
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis.阿仑单抗治疗多发性硬化症后侵袭性肺曲霉病的尸检诊断
Mult Scler. 2020 Jan;26(1):123-126. doi: 10.1177/1352458518813110. Epub 2019 Mar 18.
引用本文的文献
1
Risk of stroke under disease modifying therapies for multiple sclerosis: a systematic review.多发性硬化症疾病修正疗法下的中风风险：一项系统评价。
Ther Adv Neurol Disord. 2025 May 21;18:17562864251321669. doi: 10.1177/17562864251321669. eCollection 2025.
Zotero 插件